Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Implementing Advance Care Planning Conversation Tools in Family Practice

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03508557
Recruitment Status : Recruiting
First Posted : April 25, 2018
Last Update Posted : September 24, 2019
Sponsor:
Collaborator:
Canadian Frailty Network
Information provided by (Responsible Party):
Michelle Howard, McMaster University

Brief Summary:
This study evaluates the use of advance care planning conversation tools with patients attending their family doctor's office. Patients complete tools about their values and wishes, and a health care provider uses a structured discussion tool to talk about the patient's health condition and future wishes. The patient's family member/substitute decision-maker is encouraged to attend and be part of the discussions.

Condition or disease Intervention/treatment Phase
Frail Elderly Syndrome Chronic Disease Behavioral: Advance care planning tools Not Applicable

Detailed Description:

Structured tools are helpful for advance care planning. Tools have been developed to help with advance care planning because it is a process which has multiple steps and people involved. This study will help health care teams in primary care learn to use the tools with frail or older seriously ill patients and will evaluate the perceptions of patients, family members and health care providers, as well as the impact of having the discussions on subsequent health care interactions the patient has.

Patients complete tools about their values and wishes, and a health care provider uses a structured discussion tool to talk about the patient's health condition and future wishes. The patient's family member/substitute decision-maker is encouraged to attend and be part of the discussions.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 120 participants
Intervention Model: Single Group Assignment
Intervention Model Description: Single group before-after
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Implementing Advance Care Planning Conversation Tools in Family Practice
Actual Study Start Date : June 1, 2018
Estimated Primary Completion Date : January 1, 2020
Estimated Study Completion Date : February 1, 2020

Arm Intervention/treatment
Experimental: Advance care planning tools
Advance care planning education and structured conversation using tools
Behavioral: Advance care planning tools
Structured conversations between patients/substitute decision-maker and clinician based on education about advance care planning using locally relevant booklet/website, values clarification tool for patient engagement, clinician use of the Serious Illness Conversation Guide




Primary Outcome Measures :
  1. Advance care planning engagement [ Time Frame: 12 weeks ]
    Survey measuring domains of engagement in advance care planning


Secondary Outcome Measures :
  1. Advance care planning engagement-substitute decision maker [ Time Frame: 12 weeks ]
    survey measuring substitute decision maker domains of engagement in advance care planning

  2. Patient experience [ Time Frame: 12 weeks ]
    survey of patient experience with intervention

  3. Patient perceived impact on health care [ Time Frame: 6-9 months ]
    qualitative interviews of patients asking perceived impact of intervention on later health care use


Other Outcome Measures:
  1. Clinician experience of intervention [ Time Frame: 6 months ]
    survey of clinician experience using conversation tools

  2. Clinician confidence having advance care planning conversations [ Time Frame: 6 months ]
    survey of clinician confidence, satisfaction



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   60 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age 60 or older
  • chronic condition that may reduce life expectancy as per physician's clinical judgement
  • able to communicate verbally in English and read English

Exclusion Criteria:

  • unable to communicate verbally in English
  • unable to read English
  • cognitively unable to give informed consent (e.g. memory problems) as judged by referring physician or research assistant

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03508557


Contacts
Layout table for location contacts
Contact: Michelle Howard, PhD 905-525-9140 ext 28502 mhoward@mcmaster.ca
Contact: Dawn Elston, MA 905-525-9140 ext 21759 elstond@mcmaster.ca

Locations
Layout table for location information
Canada, Alberta
Sunridge Family Medicine Teaching Centre Recruiting
Calgary, Alberta, Canada, T1Y 5S3
Contact: Carley Paterson, BA    403-943-5000    cepaters@ucalgary.ca   
Contact: Amy Tan, MD    403-943-5000    amy.tan1@ucalgary.ca   
Canada, British Columbia
New Westminster Family Practice Recruiting
Vancouver, British Columbia, Canada, V3L 3C2
Contact: John Yap, MD    (604) 521-8522    johncpyap@gmail.com   
Contact: Rachel Carter, PhD    604-553-4866    rcarter@bc-cpc.ca   
Sponsors and Collaborators
McMaster University
Canadian Frailty Network
Investigators
Layout table for investigator information
Principal Investigator: Michelle Howard, PhD McMaster University

Layout table for additonal information
Responsible Party: Michelle Howard, Assistant Professor, McMaster University
ClinicalTrials.gov Identifier: NCT03508557     History of Changes
Other Study ID Numbers: TG2015-03D
First Posted: April 25, 2018    Key Record Dates
Last Update Posted: September 24, 2019
Last Verified: September 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Chronic Disease
Disease Attributes
Pathologic Processes